These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
323 related items for PubMed ID: 9542677
1. Epidemiology and in vitro activity of antimycotics against candidal vaginal/skin/nail infections in Singapore. Kwok YK, Tay YK, Goh CL, Kamarudin A, Koh MT, Seow CS. Int J Dermatol; 1998 Feb; 37(2):145-9. PubMed ID: 9542677 [Abstract] [Full Text] [Related]
3. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile. Sadeghi G, Ebrahimi-Rad M, Mousavi SF, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M. J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545 [Abstract] [Full Text] [Related]
4. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. J Clin Microbiol; 2005 May; 43(5):2155-62. PubMed ID: 15872235 [Abstract] [Full Text] [Related]
5. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use]. Saporiti AM, Gómez D, Levalle S, Galeano M, Davel G, Vivot W, Rodero L. Rev Argent Microbiol; 2001 May; 33(4):217-22. PubMed ID: 11833253 [Abstract] [Full Text] [Related]
6. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin]. Diaz MC, Camponovo R, Araya I, Cerda A, Santander MP, Carrillo-Muñoz AJ. Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765 [Abstract] [Full Text] [Related]
7. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. Choukri F, Benderdouche M, Sednaoui P. J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913 [Abstract] [Full Text] [Related]
8. Species distribution and antifungal susceptibility of Candida spp. isolated from superficial candidiasis in outpatients in Iran. Razzaghi-Abyaneh M, Sadeghi G, Zeinali E, Alirezaee M, Shams-Ghahfarokhi M, Amani A, Mirahmadi R, Tolouei R. J Mycol Med; 2014 Jun; 24(2):e43-50. PubMed ID: 24767256 [Abstract] [Full Text] [Related]
9. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age. Khan F, Baqai R. J Ayub Med Coll Abbottabad; 2010 Jun; 22(4):197-200. PubMed ID: 22455297 [Abstract] [Full Text] [Related]
10. [Prerequisites for effective therapy of chronic recurrent vaginal candidiasis]. Kunzelmann V, Tietz HJ, Rossner D, Czaika V, Hopp M, Schmalreck A, Sterry W. Mycoses; 1996 Jun; 39 Suppl 1():65-72. PubMed ID: 8767274 [Abstract] [Full Text] [Related]
11. [Vulvovaginal candidiasis and sensitivity of pathogens to antimycotics]. Sojáková M, Liptajová D, Simoncicová M, Borovský M, Subík J. Ceska Gynekol; 2003 Jan; 68(1):24-9. PubMed ID: 12708111 [Abstract] [Full Text] [Related]
12. Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis. Nagashima M, Yamagishi Y, Mikamo H. J Infect Chemother; 2016 Feb; 22(2):124-6. PubMed ID: 26627336 [Abstract] [Full Text] [Related]
13. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.]. Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E. Akush Ginekol (Sofiia); 2016 Feb; 55(4):20-29. PubMed ID: 29370489 [Abstract] [Full Text] [Related]
14. Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications. Spitzer M, Wiederhold NP. J Low Genit Tract Dis; 2018 Apr; 22(2):152-158. PubMed ID: 29474241 [Abstract] [Full Text] [Related]
15. In vitro antifungal resistance profile of Candida strains isolated from Saudi women suffering from vulvovaginitis. Yassin MT, Mostafa AA, Al-Askar AA, Bdeer R. Eur J Med Res; 2020 Jan 04; 25(1):1. PubMed ID: 31901238 [Abstract] [Full Text] [Related]
16. Species distribution and susceptibility of Candida isolates from patient with vulvovaginal candidiasis in Southern China from 2003 to 2012. Liu XP, Fan SR, Peng YT, Zhang HP. J Mycol Med; 2014 Jun 04; 24(2):106-11. PubMed ID: 24746725 [Abstract] [Full Text] [Related]
17. [Fungi isolated from the vagina and their susceptibility to antifungals]. Macura AB, Skóra M. Ginekol Pol; 2012 Jun 04; 83(6):433-8. PubMed ID: 22880463 [Abstract] [Full Text] [Related]
18. Antifungal susceptibility pattern of Candida species isolated from pregnant women. Ali M, Edrees WH, Al-Shehari WA, Xue G, Al-Hammadi S, Qasem EA, Chaulagain RP, Lal N. Front Cell Infect Microbiol; 2024 Jun 04; 14():1434677. PubMed ID: 39170986 [Abstract] [Full Text] [Related]
19. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens]. Skliar TV, Krysenko AV, Sirokvasha EA, Vinnikov AI. Mikrobiol Z; 2007 Jun 04; 69(3):57-62. PubMed ID: 17682532 [Abstract] [Full Text] [Related]
20. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Palacín C, Tarragó C, Agut J, Guglietta A. Methods Find Exp Clin Pharmacol; 2001 Mar 04; 23(2):61-4. PubMed ID: 11484411 [Abstract] [Full Text] [Related] Page: [Next] [New Search]